SCHEMBL2286780

SCHEMBL2286780

CC(C)c1cccc(C(C)C)c1Nc1cccc2cccnc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.52
MAPT P10636 4/20 0.49
SLC40A1 Q9NP59 4/20 0.49
TP53 P04637 1/20 0.49
HTT P42858 2/20 0.49
GLO1 Q04760 2/20 0.49
ALOX15 P16050 1/20 0.49
KMT2A Q03164 3/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
SHMT2 P34897 1/20 0.44
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2286768 0.88 TDP1 (0.52) TDP1MAPTSLC40A1TP53HTT
SCHEMBL5838972 0.81 GRM5 (0.38) TDP1MAPTSLC40A1TP53KMT2A
SCHEMBL31490195 0.79 PSMD14 (0.55) TDP1MAPTSLC40A1TP53HTT
SCHEMBL84502 0.79 PSMD14 (0.55) TDP1MAPTSLC40A1TP53HTT
SCHEMBL379216 0.79 GLO1 (0.59) TDP1MAPTSLC40A1TP53HTT
SCHEMBL21778151 0.79 GABRA1 (0.38) TDP1MAPTSLC40A1TP53GLO1
SCHEMBL21248111 0.79 SLC40A1 (0.45) TDP1MAPTSLC40A1TP53GLO1
SCHEMBL2283401 0.79 KDR (0.56) TDP1MAPTSLC40A1HTTGLO1
SCHEMBL13337941 0.76 MEN1 (0.56) TDP1MAPTSLC40A1TP53HTT
SCHEMBL28283795 0.76 MAPT (0.67) TDP1MAPTTP53HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3549960-B1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2021-03-24 EP disclosed
EP-3549960-B1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2021-03-24 EP disclosed
EP-3549960-A1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR Dow Global Technologies Llc (US) 2019-10-09 EP disclosed
EP-3549960-A1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR Dow Global Technologies Llc (US) 2019-10-09 EP disclosed
EP-2536770-B1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2019-06-05 EP disclosed
EP-2536770-B1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2019-06-05 EP disclosed
CN-102781981-B Process for polymerization of olefin monomers and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2015-09-16 CN disclosed
US-8729201-B2 Process for polymerizing an olefin monomer and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2014-05-20 US disclosed
US-8729201-B2 Process for polymerizing an olefin monomer and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2014-05-20 US disclosed
US-8729201-B2 Process for polymerizing an olefin monomer and catalyst therefor DOW GLOBAL TECHNOLOGIES LLC (US) 2014-05-20 US disclosed
EP-2536770-A2 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR Dow Global Technologies LLC (US) 2012-12-26 EP disclosed
US-20110207903-A1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC 2011-08-25 US disclosed
US-20110207903-A1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC 2011-08-25 US disclosed
US-20110207903-A1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC 2011-08-25 US disclosed
WO-2011102990-A2 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2011-08-25 WO disclosed
WO-2011102990-A2 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR DOW GLOBAL TECHNOLOGIES LLC (US) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207903-A1 PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR NOTUM, FAR1, WASF2 TDP1 2337/4885MAPT 1302/4885SLC40A1 2044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.